Remove Chronic Pain Remove Clinical Trials Remove Media Remove Topical
article thumbnail

3 Ways Florida Medical Marijuana Can Be Used to Fight Cancer

FloridaMarijuana.net

Mainstream media has begun to illustrate just how effective medical marijuana can be in helping cancer patients. There are 3 ways Florida medical marijuana can be used to treat cancer: Topical: Topical applications, through a cream, salve or lotion, infused with medical marijuana can be applied directly to your skin.

article thumbnail

Breaking the Stigma: Shifting Attitudes Toward Medical Marijuana Nationwide

MMJ Recs

Medical marijuana, once a controversial and stigmatized topic, has undergone a remarkable transformation in the eyes of the American public. Studies have shown the efficacy of medical cannabis in treating conditions such as chronic pain, epilepsy, and certain mental health disorders.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How to fit CBD products into your alternative health regimen

The Cannigma

The constant distractions, notifications, and social media outrages of the day can also boost your anxiety and stress, and make it much harder to just live in the moment. Both THC and CBD rich products may help those suffering from pain lasting several months. Types of cannabis products.

CBD 75
article thumbnail

Curaleaf shares down 8% after FDA sends warning letter over CBD health claims

Cannabis Law Report

1 We have also reviewed your social media websites at www.facebook.com/CuraleafHemp External Link Disclaimer and [link] External Link Disclaimer ; these websites direct consumers to your website, [link] External Link Disclaimer , to purchase your products. Chronic or arthritic pain.”. Chronic pain.

CBD 51
article thumbnail

Virpax Announces Clinical Trial Site in Canada for First in Human Study of Epoladerm™ for Pain Associated with Osteoarthritis of the Knee

Cannabis Law Report

(“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications, signed a clinical trial agreement with Altasciences Company, Inc., Media: Laura Radocaj. Chipman, CPA. Chief Financial Officer. Investor Relations: Betsy Brod.

article thumbnail

Virpax Reports Successful Results of Toxicology and Pharmacokinetic Study for Epoladerm™

Cannabis Law Report

Charles River Laboratories, a renowned CRO engaged by Virpax to perform Food and Drug Administration (FDA) required pre-clinical studies, has completed a single dose pharmacokinetic study of dermal administration of Epoladerm in minipigs as part of the required Investigational New Drug Application (“IND”) enabling trials.

article thumbnail

Virpax Advances Envelta™ Development with NCATS Under CRADA Agreement

Cannabis Law Report

The NIH has also engaged a firm to manufacture Leu-enkephalin (L-ENK), the active ingredient in Envelta and a firm to manufacture the Molecular Envelope Technology (MET) that is used to carry the L-ENK to the brain to promptly suppress pain. Media: Laura Radocaj. In October 2021, Virpax announced that a $1.87 Christopher M. Betsy Brod.